Centene raises 2025 revenue guidance by $4B while maintaining EPS target
The company reported a Q4 adjusted diluted EPS of $0.80 and full-year 2024 adjusted diluted EPS of $7.17, exceeding prior guidance. Revenue guidance for 2025 was raised by $4B to a range of $158B to ...
Cigna projects 2025 EPS of at least $29.50 amid biosimilar growth and strategic investments
CEO David Cordani highlighted Cigna's full-year revenue growth of $247 billion, a 27% increase, alongside adjusted EPS of $27.33, which fell short of expectations. He reaffirmed the company's ...